Effect of alginate composition and purity on alginate microspheres

References

• AMERICAN DIABETES ASSOCIATION, 1998, Economic consequences of diabetes in the US in 1997. Diabetes Care, 21, 296–309.
   PubMed Web of Science ®Google Scholar
• CALDARA, R., LA ROCCA, E., MAFFI, P. and SECCHI, A., 1999, Effects of pancreas transplantation on late complications of diabetes and metabolic effects of pancreas and islet transplantation. Journal of Pediatric Endocrinology Metabolism, 12, 777–787.
   PubMed Web of Science ®Google Scholar
• CHICHEPORTICHE, D. and REACH, G., 1988, In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of microcapsules. Diabetologia, 31, 54–57.
   PubMed Web of Science ®Google Scholar
• CONSTANTINIDIS, I., RASK, I., LONG, R. C., and SAMBANIS, A., 1999, Effect of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells. Biomaterials, 20, 2019–2097.
   PubMed Web of Science ®Google Scholar
• DARRABIE, M., FREEMAN, B. K., KENDAL, W. F., HOBBS, H. A. and OPARA, E. C., 2001, Durability of sodium sulfate-treated polylysine-alginate microcapsules. Journal of Biomedical Materials Research, 54, 396–399.
   PubMed Web of Science ®Google Scholar
• DE VOS, P., DE HAAN, B., PATER, J. and VAN SCHILFGAARDE, R., 1996, Association between capsule diameter, adequacy of encapsulation and survival of microencapsulated rat islet allografts. Transplantation, 62, 893–899.
   PubMed Web of Science ®Google Scholar
• DIABETES CONTROL AND COMPLICATIONS TRIAL (DCCT), 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977–986.
   Google Scholar
• EKBERG, K., BRISMAR, T., JOHANSSON, B.-L., JoNssoN, B., LINDSTROM, P. and WAHREN, J., 2003, Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes, 52, 536–541.
   Google Scholar
• FIORETTO, P., STEFFES, M. W., SUTHERLAND, D. E., GOETZ, F. C. and MAUER, M., 1998, Reversal of lesions of diabetic nephropathy after pancreas transplantation. New England Journal of Medicine, 339, 69–75.
   PubMed Web of Science ®Google Scholar
• GARFINKEL, M. R., HARLAND, R. C. and OPARA, E. C., 1998, Optimization of the microencapsulated islet for transplantation. Journal of Surgery Research, 76, 7–10.
   PubMed Web of Science ®Google Scholar
• HANSEN, A., JOHANSSON, B.-L., WAHREN, J. and VON BIBRA, H., 2002, C-peptide exerts beneficial effects on myocardial blood flow and function in patients with Type 1 diabetes. Diabetes, 51, 3077–3082.
   Google Scholar
• Howis, H. A., KENDALL, W. F., DARRABIE, M. and OPARA, E. C., 2001, Prevention of morphological changes in alginate microcapsules for islet xenotransplantation. Journal of Investigative Medicine, 49, 572–575.
   PubMed Web of Science ®Google Scholar
• IDo, Y., VINDIGNI, A., CHANG, K., STRAMM, L., CHANCE, R., HEATH, W. F., DIMARCHI, R. D., DI CERA, E. and WILLIAMSON, J. R., 1997, Prevention of vascular and neural dysfunction in diabetic rats by c-peptide. Science, 277, 563–566.
   PubMed Web of Science ®Google Scholar
• JOHNSON, B., 1998, The economic impact of diabetes. Diabetes Care, 21(Suppl 3), C7—C10. KENDALL, W. F., COLLINS, B. H. and OPARA, E. C., 2001, Islet cell transplantation for the treatment of diabetes mellitus. Expert Opinions in Biological Therapy, 1, 109-119. OPARA, E. C., 1998, The therapeutic potential of islet cell transplant in the treatment of diabetes. Expert Opinions in Investigative Drugs, 7, 785–795.
   PubMedGoogle Scholar
• OPARA, E. C. and KENDALL, W. F. JR., 2002, Immunoisolation techniques for islet cell transplantation. Expert Opinions in Biological Therapy, 2, 503–511.
   PubMed Web of Science ®Google Scholar
• ORLOFF, M. J., GREENLEAF, G. E., URBAN, P. and GIRARD, B., 1986, Lifelong reversal of the metabolic abnormalities of advanced diabetes in rats by whole-pancreas transplantation. Transplantation, 41, 556–564.
   PubMed Web of Science ®Google Scholar
• PYKE, D., 1991, Pancreas transplantation. Diabetes-Metabolism Review, 7, 3–14.
   PubMed Web of Science ®Google Scholar
• SAFRAN, M. A. and VINICOR, F., 1999, The war against diabetes. How will we know if we are winning? Diabetes Care, 22(3), 508–516.
   Google Scholar
• SAMBANIS, A., 2000, Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes. Diabetes Technology Therapeutics, 2, 81–89.
   PubMedGoogle Scholar
• SCHREZENMEIR, J., KIRCHGESSNER, J., GERO, L., KUN, L. A., BEYER, J. and MUELLER-KLIESER, W., 1994, Effect of microencapsulation on oxygen distribution in islet organs. Transplantation, 57, 1308–1314.
   Google Scholar
• SHAPIRO, A. M. J., LAKEY, J. R. T., RYAN, E. A., KORBUTT, G. S., TOTH, E., WARNOCK, G. L., KNETEMAN, N. M. and RMOTTE, R. V., 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppres-sive regimen. New England Journal of Medicine, 343, 230–238.
   Google Scholar
• SMIDSROD, 0. and SKJAK-BRAEK, G., 1990, Alginate as an immobilization matrix for cells. Trends in Biotechnology, 8, 71–78.
   Google Scholar
• STABLER, C., WILKS, K., SAMBANIS, A. and CONSTANTINIDIS, I., 2001, The effects of alginate composition on encapsulated beta TC3 cells. Biomaterials, 22, 1301–1310.
   PubMed Web of Science ®Google Scholar
• WOLTERS, G. H., FRITSCHY, W. M., GERRITS, D. and VAN SCHILFGAARDE, R., 1992, A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. Journal of Applied Biomaterials, 3, 281–286.
   Google Scholar